Gazing into the crystal ball; The future of computer-aided drug design

Journal of Computer-Aided Molecular Design

Volumn 26, Issue 1, 2012, Pages 77-79

  Martin, Eric ^a   Ertl, Peter ^b   Hunt, Peter ^a   Duca, Jose ^a   Lewis, Richard ^b  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER AIDED DRUG DESIGN; CRYSTAL BALLS;

ACCURACY; BIOINFORMATICS; CHEMICAL STRUCTURE; CHEMOMETRIC ANALYSIS; COMPUTER AIDED DESIGN; COMPUTER SIMULATION; DRUG DESIGN; DRUG INDUSTRY; HIGH THROUGHPUT SCREENING; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MODEL; PREDICTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RELIABILITY; REVIEW; SYSTEMATIC ERROR; THERMODYNAMICS; VALIDATION PROCESS;

EID: 84857453301     PISSN: 0920654X     EISSN: 15734951     Source Type: Journal    
DOI: 10.1007/s10822-011-9487-0     Document Type: Review

References (0)